Rich Horgan (L) with his late brother, Terry (Cure Rare Disease via YouTube)

Pa­tient who re­ceived cus­tom gene ther­a­py like­ly died from im­mune re­ac­tion, not CRISPR, pa­per says

Re­searchers be­lieve that Ter­ry Hor­gan, a 27-year-old man with Duchenne mus­cu­lar dy­s­tro­phy who was the first per­son to re­ceive a de­sign­er CRISPR ther­a­py, died from an im­mune re­ac­tion like­ly re­lat­ed to the high dose of vi­ral vec­tor used to de­liv­er the ther­a­py.

A preprint pa­per pub­lished Wednes­day de­scribed find­ings from Ter­ry’s au­top­sy, fol­low­ing months of un­cer­tain­ty around what ex­act­ly led to his death in Oc­to­ber just eight days af­ter he re­ceived the treat­ment. The re­searchers con­clud­ed that Ter­ry’s death was not like­ly re­lat­ed to gene edit­ing, since there was on­ly a small sig­nal of the CRISPR ex­pres­sion in the liv­er, and none in oth­er or­gans.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.